Related Experiment Video
Updated: Feb 16, 2026

07:13
An Alternative and Validated Injection Method for Accessing the Subretinal Space via a Transcleral Posterior Approach
Published on: December 7, 2016
14.0K
Intravitreal injection of polysorbate 80: a functional and morphological study
Francisco Max Damico1, Fábio Gasparin1, Gabriela Lourençon Ioshimoto2
1- USP Medical School, Department of Ophthalmology and Otolaryngology, São Paulo, SP, Brazil.
Revista Do Colegio Brasileiro De Cirurgioes
|December 22, 2017
Summary
Polysorbate 80 (PS80) at concentrations used for intravitreal drug formulations showed no adverse effects on rabbit retinas. This study indicates PS80 is safe for preparing new intravitreal medications.
Area of Science:
- Ophthalmology
- Pharmacology
- Toxicology
Background:
- Polysorbate 80 (PS80) is a common excipient in pharmaceutical formulations.
- Its safety for intravitreal injection, particularly in drug preparations, requires thorough evaluation.
- Understanding PS80's effects on retinal tissue is crucial for developing new ophthalmic treatments.
Purpose of the Study:
- To assess the functional and morphological impact of PS80 on rabbit retinas.
- To determine the safety of PS80 concentrations used in intravitreal drug preparation.
Main Methods:
- Intravitreal injections of PS80 were administered to New Zealand rabbits.
- Control eyes received saline injections.
- Functional assessment included electroretinography (ERG), biomicroscopy, and retinal mapping.
- Morphological analysis was performed using light microscopy post-euthanasia.
Main Results:
- No clinical signs of intraocular inflammation were observed in PS80-injected eyes.
- ERG measurements showed no significant alterations in scotopic or photopic conditions.
- Light microscopy revealed no morphological changes in the retinas.
Conclusions:
- Intravitreal PS80, at concentrations relevant to drug preparation, does not induce functional or morphological retinal damage in rabbits.
- PS80 demonstrates a lack of toxicity to rabbit retinas.
- These findings support the safe use of PS80 in novel lipophilic intravitreal drug formulations.

